إعلان
إعلان
PBYI
PUMA BIOTECHNOLOGY INC
6.12
USDبرعاية
-0.08
-1.37%
٠٩ يناير, ١٥:٥٨ UTC -5
مغلق
بعد الإغلاق
6.12
0.00
0.00%
تقارير أرباح PBYI
النسبة الإيجابية المفاجئة
PBYI تفوق 29 من 40 آخر التقديرات.
73%
التقرير التالي
بيانات التقرير القادم
٢٥ فبراير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$69.97M
/$0.19
التغير الضمني من Q3 25 (Revenue/ EPS)
+28.39%
/+11.76%
التغير الضمني من Q4 24 (Revenue/ EPS)
+18.40%
/-51.28%
PUMA BIOTECHNOLOGY INC earnings per share and revenue
On ٠٦ نوفمبر ٢٠٢٥, PBYI reported earnings of 0.17 USD per share (EPS) for Q3 25, beating the estimate of 0.04 USD, resulting in a 270.37% surprise. Revenue reached 54.50 مليون, compared to an expected 52.02 مليون, with a 4.77% difference. The market reacted with a +22.24% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 المحللين forecast an EPS of 0.19 USD, with revenue projected to reach 69.97 مليون USD, implying an زيادة of 11.76% EPS, and زيادة of 28.39% in Revenue from the last quarter.
الأسئلة الشائعة
What were PUMA BIOTECHNOLOGY INC's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, PUMA BIOTECHNOLOGY INC reported EPS of $0.17, beating estimates by 270.37%, and revenue of $54.50M, 4.77% above expectations.
How did the market react to PUMA BIOTECHNOLOGY INC's Q3 2025 earnings?
The stock price moved up 22.24%, changed from $4.90 before the earnings release to $5.99 the day after.
When is PUMA BIOTECHNOLOGY INC expected to report next?
The next earning report is scheduled for ٢٥ فبراير ٢٠٢٦.
What are the forecasts for PUMA BIOTECHNOLOGY INC's next earnings report?
Based on 4
المحللين, PUMA BIOTECHNOLOGY INC is expected to report EPS of $0.19 and revenue of $69.97M for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان